Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2007, Article ID 93148, 9 pages
http://dx.doi.org/10.1155/2007/93148
Research Article

Inhibitory Effect of Inflexinol on Nitric Oxide Generation and iNOS Expression via Inhibition of NF-κB Activation

1College of Pharmacy and CBITRC, Chungbuk National University 12, Gaesin-dong, Heungduk-gu, Cheongju, Chungbuk 361-763, South Korea
2National Institute of Environmental Research, Kyungseo-dong, Seo-gu, Incheon 404-780, South Korea
3Department of Medical Beauty, Konyang University, 26 Nae-dong, Nonsan, Chungnam 320-711, South Korea

Received 6 October 2006; Accepted 24 January 2007

Copyright © 2007 Jae Woong Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. L. Wallace, “Nitric oxide as a regulator of inflammatory processes,” Memorias do Instituto Oswaldo Cruz, vol. 100, supplement 1, pp. 5–9, 2005. View at Google Scholar
  2. E. Moilanen, B. Whittle, and S. Moncada, “Nitric oxide as a factor in inflammation,” in Inflammation: Basic Principles and Clinical Correlates, J. I. Gallin and R. Snyderman, Eds., pp. 787–800, Williams and Wilkins, Philadelphia, Pa, USA, 1999. View at Google Scholar
  3. A. J. Hobbs, A. Higgs, and S. Moncada, “Inhibition of nitric oxide synthase as a potential therapeutic target,” Annual Review of Pharmacology and Toxicology, vol. 39, pp. 191–220, 1999. View at Publisher · View at Google Scholar
  4. R. Luna-Medina, M. Cortes-Canteli, M. Alonso, A. Santos, A. Martínez, and A. Perez-Castillo, “Regulation of inflammatory response in neural cells in vitro by thiadiazolidinones derivatives through peroxisome proliferator-activated receptor γ activation,” Journal of Biological Chemistry, vol. 280, no. 22, pp. 21453–21462, 2005. View at Publisher · View at Google Scholar
  5. Y. S. Shibakawa, Y. Sasaki, Y. Goshima et al., “Effects of ketamine and propofol on inflammatory responses of primary glial cell cultures stimulated with lipopolysaccharide,” British Journal of Anaesthesia, vol. 95, no. 6, pp. 803–810, 2005. View at Publisher · View at Google Scholar
  6. J. R. Vane, J. A. Mitchell, I. Appleton et al., “Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, pp. 2046–2050, 1994. View at Publisher · View at Google Scholar
  7. T. A. Swierkosz, J. A. Mitchell, T. D. Warner, R. M. Botting, and J. R. Vane, “Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids,” British Journal of Pharmacology, vol. 114, no. 7, pp. 1335–1342, 1995. View at Google Scholar
  8. J. R. Vane and R. M. Botting, “Anti-inflammatory drugs and their mechanism of action,” Inflammation Research, vol. 47, supplement 2, pp. 78–87, 1998. View at Publisher · View at Google Scholar
  9. S.-J. Yeo, J.-G. Yoon, and A.-K. Yi, “Myeloid differentiation factor 88-dependent post-transcriptional regulation of cyclooxygenase-2 expression by CpG DNA: tumor necrosis factor-α receptor-associated factor 6, a diverging point in the Toll-like receptor 9-signaling,” Journal of Biological Chemistry, vol. 278, no. 42, pp. 40590–40600, 2003. View at Publisher · View at Google Scholar
  10. Y.-M. Kim, B.-S. Lee, K.-Y. Yi, and S.-G. Paik, “Upstream NF-κB site is required for the maximal expression of mouse inducible nitric oxide synthase gene in interferon-γ plus lipopolysaccharide-induced RAW 264.7 macrophages,” Biochemical and Biophysical Research Communications, vol. 236, no. 3, pp. 655–660, 1997. View at Publisher · View at Google Scholar
  11. A. Kumar, Y. Takada, A. M. Boriek, and B. B. Aggarwal, “Nuclear factor-κB: its role in health and disease,” Journal of Molecular Medicine, vol. 82, no. 7, pp. 434–448, 2004. View at Publisher · View at Google Scholar
  12. T. M. Lindström and P. R. Bennett, “The role of nuclear factor κB in human labour,” Reproduction, vol. 130, no. 5, pp. 569–581, 2005. View at Publisher · View at Google Scholar
  13. N. L. Malinin, M. P. Boldin, A. V. Kovalenko, and D. Wallach, “MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1,” Nature, vol. 385, no. 6616, pp. 540–544, 1997. View at Publisher · View at Google Scholar
  14. B. Y. Hwang, J.-H. Lee, T. H. Koo et al., “Kaurane diterpenes from Isodon japonicus inhibit nitric oxide and prostaglandin E2 production and NF-?B activation in LPS-stimulated macrophage RAW264.7 cells,” Planta Medica, vol. 67, no. 5, pp. 406–410, 2001. View at Publisher · View at Google Scholar
  15. J.-H. Lee, T. H. Koo, B. Y. Hwang, and J. J. Lee, “Kaurane diterpene, kamebakaurin, inhibits NF-κB by directly targeting the DNA-binding activity of p50 and blocks the expression of antiapoptotic NF-κB target genes,” Journal of Biological Chemistry, vol. 277, no. 21, pp. 18411–18420, 2002. View at Publisher · View at Google Scholar
  16. F. Nagashima, M. Kondoh, M. Kawase et al., “Apoptosis-inducing properties of ent-kaurene-type diterpenoids from the liverwort Jungermannia truncata,” Planta Medica, vol. 69, no. 4, pp. 377–379, 2003. View at Publisher · View at Google Scholar
  17. A. Castrillo, B. De las Heras, S. Hortelano, B. Rodríguez, A. Villar, and L. Boscá, “Inhibition of the nuclear factor κB (NF-κB) pathway by tetracyclic kaurene diterpenes in macrophages: specific effects on NF-κB-inducing kinase activity and on the coordinate activation of ERK and p38 MAPK,” Journal of Biological Chemistry, vol. 276, no. 19, pp. 15854–15860, 2001. View at Publisher · View at Google Scholar
  18. J.-H. Lee, T. H. Koo, B. Y. Hwang, and J. J. Lee, “Kaurane diterpene, kamebakaurin, inhibits NF-κB by directly targeting the DNA-binding activity of p50 and blocks the expression of antiapoptotic NF-κB target genes,” Journal of Biological Chemistry, vol. 277, no. 21, pp. 18411–18420, 2002. View at Publisher · View at Google Scholar
  19. T. Fujita, Y. Takeda, E. Yuasa, A. Okamura, T. Shingu, and T. Yokoi, “Structure of inflexinol, a new cytotoxic diterpene from Rabdosia inflexa,” Phytochemistry, vol. 21, no. 4, pp. 903–905, 1982. View at Publisher · View at Google Scholar
  20. J. Nath and A. Powledge, “Modulation of human neutrophil inflammatory responses by nitric oxide: studies in unprimed and LPS-primed cells,” Journal of Leukocyte Biology, vol. 62, no. 6, pp. 805–816, 1997. View at Google Scholar
  21. P. A. Baeuerle, “The inducible transcription activator NF-κB: regulation by distinct protein subunits,” Biochimica et Biophysica Acta—Reviews on Cancer, vol. 1072, no. 1, pp. 63–80, 1991. View at Publisher · View at Google Scholar
  22. L. C. Denlinger, P. L. Fisette, K. A. Garis et al., “Regulation of inducible nitric oxide synthase expression by macrophage purinoreceptors and calcium,” Journal of Biological Chemistry, vol. 271, no. 1, pp. 337–342, 1996. View at Publisher · View at Google Scholar
  23. S. Ortega-Gutiérrez, E. Molina-Holgado, and C. Guaza, “Effect of anandamide uptake inhibition in the production of nitric oxide and in the release of cytokines in astrocyte cultures,” GLIA, vol. 52, no. 2, pp. 163–168, 2005. View at Publisher · View at Google Scholar
  24. J. Berg, H. Fellier, T. Christoph, J. Grarup, and D. Stimmeder, “The analgesic NSAID lornoxicam inhibits cyclooxygenase (COX)-1/-2, inducible nitric oxide synthase (iNOS), and the formation of interleukin (IL)-6 in vitro,” Inflammation Research, vol. 48, no. 7, pp. 369–379, 1999. View at Publisher · View at Google Scholar
  25. K. Yoon, K. Soliman, and K. Redda, “Inhibitory effects of N-(substituted benzoylamino)-4-ethyl-1,2,3,6-tetrahydropyridines on nitric oxide generation in stimulated raw 264.7 macrophages,” Drugs under Experimental and Clinical Research, vol. 28, no. 2-3, pp. 83–90, 2002. View at Google Scholar
  26. C.-H. Leung, S. P. Grill, W. Lam, Q.-B. Han, H.-D. Sun, and Y.-C. Cheng, “Novel mechanism of inhibition of nuclear factor-κB DNA-binding activity by diterpenoids isolated from Isodon rubescens,” Molecular Pharmacology, vol. 68, no. 2, pp. 286–297, 2005. View at Publisher · View at Google Scholar
  27. S. P. Hehner, M. Heinrich, P. M. Bork et al., “Sesquiterpene lactones specifically inhibit activation of NF-?B by preventing the degradation of I?B-a and I?B-ß,” Journal of Biological Chemistry, vol. 273, no. 3, pp. 1288–1297, 1998. View at Publisher · View at Google Scholar
  28. S. H. Lee, S. Y. Lee, D. J. Son et al., “Inhibitory effect of 2'-hydroxycinnamaldehyde on nitric oxide production through inhibition of NF-?B activation in RAW 264.7 cells,” Biochemical Pharmacology, vol. 69, no. 5, pp. 791–799, 2005. View at Publisher · View at Google Scholar
  29. S. H. Lee, C. W. Lee, J. W. Lee et al., “Induction of apoptotic cell death by 2'-hydroxycinnamaldehyde is involved with ERK-dependent inactivation of NF-?B in TNF-a-treated SW620 colon cancer cells,” Biochemical Pharmacology, vol. 70, no. 8, pp. 1147–1157, 2005. View at Publisher · View at Google Scholar
  30. B. H. B. Kwok, B. Koh, M. I. Ndubuisi, M. Elofsson, and C. M. Crews, “The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IκB kinase,” Chemistry and Biology, vol. 8, no. 8, pp. 759–766, 2001. View at Publisher · View at Google Scholar